FMP

FMP

Enter

IMRX - Immuneering Cor...

photo-url-https://financialmodelingprep.com/image-stock/IMRX.png

Immuneering Corporation

IMRX

NASDAQ

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.

2.43 USD

-0.04 (-1.65%)

About

ceo

Dr. Benjamin J. Zeskind M.B.A., Ph.D.

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharma...

CIK

0001790340

ISIN

US45254E1073

CUSIP

45254E107

Address

245 Main Street

Phone

617 500 8080

Country

US

Employee

66

IPO Date

Jul 30, 2021

IMRX Financial Summary

CIK

0001790340

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

45254E107

ISIN

US45254E1073

Country

US

Price

2.43

Beta

-0.45

Volume Avg.

6.28M

Market Cap

72.06M

Shares

-

52-Week

1.0-8.89

DCF

1.93

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.28

P/B

-

Website

https://immuneering.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest IMRX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep